Reviewer Policies
Conflict of Interest and Financial Disclosures (specific to reviewers)
Cancer Studies and Molecular Medicine – Open Journal requires all reviewers to disclose any potential conflicts of interest (COI) prior to accepting a manuscript for review. A COI may arise if the reviewer has a financial, professional, or personal relationship with the author(s) or any related institutions that could influence their impartiality. Reviewers must complete a COI disclosure form and recuse themselves from reviewing manuscripts where they have a direct or indirect conflict, such as shared research funding, institutional affiliations, or personal relationships with the authors. Additionally, any financial interest in the research outcomes (such as investment in a related company or stock ownership) should be disclosed. The journal aims to ensure that the review process remains unbiased and fair, with decisions based solely on the quality and scientific merit of the work. If a COI is disclosed, the editorial team may choose to assign the manuscript to another reviewer. In cases where a COI arises during the review process, reviewers are expected to notify the editorial team immediately. The integrity of the review process is paramount, and Cancer Studies and Molecular Medicine – Open Journal takes every step to ensure impartial evaluations through transparent COI management.
Reviewers Guidelines
Cancer Studies and Molecular Medicine – Open Journal provides detailed guidelines for reviewers to ensure that the peer review process is rigorous, fair, and constructive. Reviewers are selected based on their expertise in the relevant field of research and are tasked with providing an impartial and thorough evaluation of the manuscript. Reviewers should assess the manuscript for scientific quality, originality, validity of the methodology, clarity of the writing, and relevance to the journal’s scope. They are expected to provide clear, actionable feedback, highlighting strengths and weaknesses in the study, and suggesting improvements to help authors refine their work. Reviewers are also encouraged to evaluate the ethical aspects of the research, including issues of authorship, plagiarism, data integrity, and the handling of human or animal subjects. Importantly, reviewers should maintain confidentiality throughout the process, refraining from discussing the manuscript’s content with others and not using any information from the manuscript for personal gain. Reviewers should also declare any conflicts of interest before accepting an invitation to review and recuse themselves from the review if such conflicts exist. Cancer Studies and Molecular Medicine – Open Journal values constructive, timely, and honest feedback from reviewers, ensuring that the publication process maintains the highest standards of scientific integrity.
